Massimo Loda

Active 1992–2025

269
Papers
69,956
Citations
133
h-index
262
i10-index

Citations

Citations per year for Massimo Loda1921: 1 citations1932: 1 citations1948: 1 citations1976: 2 citations1977: 1 citations1981: 1 citations1986: 2 citations1987: 1 citations1988: 1 citations1989: 1 citations1992: 3 citations1994: 1 citations1995: 6 citations1996: 15 citations1997: 51 citations1998: 143 citations1999: 194 citations2000: 186 citations2001: 273 citations2002: 322 citations2003: 444 citations2004: 591 citations2005: 599 citations2006: 618 citations2007: 608 citations2008: 673 citations2009: 799 citations2010: 917 citations2011: 881 citations2012: 858 citations2013: 841 citations2014: 832 citations2015: 753 citations2016: 789 citations2017: 852 citations2018: 825 citations2019: 2,083 citations2020: 2,598 citations2021: 2,783 citations2022: 2,061 citations2023: 1,364 citations2024: 1,911 citations2025: 955 citations2026: 53 citations1922–1931: no citations, so these years are not shown1933–1947: no citations, so these years are not shown1949–1975: no citations, so these years are not shown1978–1980: no citations, so these years are not shown1982–1985: no citations, so these years are not shown1990–1991: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 10,648 citing papers, 31.9% of this breakdownChina: 3,892 citing papers, 11.7% of this breakdownUnited Kingdom: 1,997 citing papers, 6% of this breakdownGermany: 1,436 citing papers, 4.3% of this breakdownItaly: 1,340 citing papers, 4% of this breakdownCanada: 1,339 citing papers, 4% of this breakdownAustralia: 963 citing papers, 2.9% of this breakdownFrance: 963 citing papers, 2.9% of this breakdownJapan: 921 citing papers, 2.8% of this breakdownSpain: 806 citing papers, 2.4% of this breakdownNetherlands: 663 citing papers, 2% of this breakdownSwitzerland: 595 citing papers, 1.8% of this breakdown
0%31.9%Other 23.3%

Fields

  • Biochemistry, Genetics and Molecular Biology46.5%
  • Medicine42.4%
  • Immunology and Microbiology4%
  • Computer Science3.2%
  • Engineering0.9%
  • Neuroscience0.7%
  • Other2.3%

Topics

  • Prostate Cancer Treatment and Research4.9%
  • Gene expression and cancer classification2.9%
  • Cancer Genomics and Diagnostics2.7%
  • Epigenetics and DNA Methylation2.7%
  • Cancer, Lipids, and Metabolism2.1%
  • Cancer-related Molecular Pathways1.9%
  • Other82.8%

Coauthors

All papers

Open in search
  1. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 3,701

  2. Genomic correlates of clinical outcome in advanced prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce Montgomery, Himisha Beltran, Elisabeth I. Heath, Howard I. Scher, Philip W. Kantoff, Mary‐Ellen Taplin, Nikolaus Schultz, Johann S. de Bono, Francesca Demichelis, Peter S. Nelson, Mark A. Rubin, Arul M. Chinnaiyan, Charles L. Sawyers - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 1,408

  3. The landscape of somatic copy-number alteration across human cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth A. Maher, Frederic J. Kaye, Hidefumi Sasaki, Joel E. Tepper, Jonathan A. Fletcher, Josep Tabernero, José Baselga, Ming‐Sound Tsao, Francesca Demichelis, Mark A. Rubin, Pasi A. Jänne, Mark J. Daly, Carmelo Nucera, Ross L. Levine, Benjamin L. Ebert, Stacey Gabriel, Anil K. Rustgi, Cristina R. Antonescu, Marc Ladanyi, Anthony Letai, Levi A. Garraway, Massimo Loda, David G. Beer, Lawrence D. True, Aikou Okamoto, Scott L. Pomeroy, Samuel Singer, Todd R. Golub, Eric S. Lander, Gad Getz, William R. Sellers, Matthew Meyerson - Nature 2010 cited by 4,185

  4. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Blood 2020 cited by 1,534

  5. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance

    Authors: , , , , , , , , , , , , , , , , - Science 2017 cited by 1,122

  6. Federated benchmarking of medical artificial intelligence with MedPerf

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor Bittorf, Sreekar Reddy Puchala, Biagio Ricciuti, Soujanya Samineni, Eshna Sengupta, Akshay Chaudhari, Cody Coleman, Bala Desinghu, Gregory F. Diamos, Debo Dutta, Diane Feddema, Grigori Fursin, Xinyuan Huang, Satyananda Kashyap, Nicholas D. Lane, Indranil Mallick, Pietro Mascagni, Virendra Mehta, Cassiano Ferro Moraes, Vivek Natarajan, Nikola Nikolov, Nicolas Padoy, Gennady Pekhimenko, Vijay Janapa Reddi, G. Anthony Reina, Pablo Ribalta, Abhishek Singh, Jayaraman J. Thiagarajan, Jacob Albrecht, Thomas Wolf, Geralyn Miller, Huazhu Fu, Prashant Shah, Daguang Xu, Poonam Yadav, David Talby, Mark M. Awad, Jeremy P. Howard, Michael Rosenthal, Luigi Marchionni, Massimo Loda, Jason M. Johnson, Spyridon Bakas, Peter Mattson - Nature Machine Intelligence, Nat. Mac. Intell. 2023 cited by 149

  7. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

    Authors: , , , , , , , , - Advanced Drug Delivery Reviews 2020 cited by 642

  8. Targeting potential drivers of COVID-19: Neutrophil extracellular traps

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2020 cited by 1,583

  9. Gene expression correlates of clinical prostate cancer behavior

    Authors: , , , , , , , , , , , , , , - Cancer Cell 2002 cited by 2,537

  10. The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William L. Dahut, Peter S. Nelson - Clinical Cancer Research 2019 cited by 394

  11. EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Housheng Hansen He, Matthew L. Freedman, Steven P. Balk, Massimo Loda, David P. Labbé, Brian M. Olson, Leigh Ellis - Nature Cancer 2021 cited by 241

  12. EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science 2012 cited by 887

  13. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis

    Authors: , , , , , , , , , , , , , , , , , - Nature Genetics 2015 cited by 490

  14. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

    Authors: , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 2,586

  15. Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis

    Authors: , , , , , , , , , , , , - Clinical Cancer Research 2023 cited by 54

  16. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer

    Authors: , , , , , , , , , , - European Urology 2018 cited by 269

  17. MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew L. Freedman, X. Shirley Liu, Myles Brown, Henry W. Long, David P. Labbé - Nature Communications 2022 cited by 156

  18. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 591

  19. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen R. Plymate, Massimo Loda - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 291

  20. Multiclass cancer diagnosis using tumor gene expression signatures

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 2,046

  21. Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing

    Authors: , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 358

  22. Fatty Acid Synthase As a Potential Therapeutic Target in Cancer

    Authors: , , , - Future Oncology 2010 cited by 542

  23. A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors

    Authors: , , , , , , , , , , - eLife 2020 cited by 143

  24. Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 88